Oxford Immunotec Global Plc (OXFD) Return on Assets ROA from the third quarter of 2020 to third quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Oxford Immunotec Global Plc  (NASDAQ: OXFD)


Oxford Immunotec Global Plc's ROA from the third quarter of 2020 to the third quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Oxford Immunotec Global Plc's ROA in the third quarter of 2020?
Oxford Immunotec Global Plc recorded a cumulative net loss of $-17 million during 12 months ending in the third quarter of 2020, resulting in a negative return on assets (ROA) of -8.2%.

However, within the Healthcare sector 261 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2020 from 3189 to 3214.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Total Assets Change -15.01 % -16.93 % -9.21 % -1.11 % 141.96 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -17 -17 -6 -2 141
Return On Assets (TTM) -8.2 % -7.48 % -2.73 % -0.76 % 59.04 %
OXFD's Total Ranking # 3214 # 3189 # 2960 # 3253 # 78
Total Assets (TTM) in million 203 201 219 230 239
Seq. Total Assets Change 1.01 % -8.22 % -4.56 % -3.94 % -1.27 %
Seq. Net Income Change - - - - 21.53 %

OXFD's 5 Years Annual ROA >> Back to OXFD Management Effectiveness >> Compare OXFD ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 7
Sector # 262
Overall # 3110

Return On Assets Statistics
High Average Low
77.79 %
-5.68 %
-38.13 %
(Dec 31 2018)   (Sep 30 2017)





Financial Statements
Oxford Immunotec Global Plc's Assets $ 203 million OXFD's Balance sheet
Oxford Immunotec Global Plc's Income $ 0 million Quarterly OXFD's Income Statement
OXFD's Income by Division See OXFD's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015
Y / Y Total Assets Change 1.35 % 60.93 % 16.31 % 12.89 % 48.75 %
Total Assets in million 235 232 144 124 110
Y / Y Net Income Change - - - - -
Net Income in million -2 121 -33 -22 -24
Annual Return On Assets -0.77 % 52.03 % -22.8 % -18.02 % -22.28 %

OXFD's 5 Years Annual ROA >> Back to OXFD Management Effectiveness >> Compare OXFD ROA to its Competitors



More Return On Assets Ratios
OXFD's' Return on Assets at Yahoo Finance
In Vitro & In Vivo Diagnostic Substances Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
OXFD's Roa Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for OXFD's Competitors
Subscribers only: Roa for Oxford Immunotec Global Plc's Suppliers
Subscribers only: Return On Assets for OXFD's Customers

You may also want to know
OXFD's Roi OXFD's Inventory Turnover Ratio OXFD's Growth Rates OXFD's Dividend Comparisons
OXFD's Profitability Ratios OXFD's Asset Turnover Ratio OXFD's Dividend Growth
OXFD's Roe OXFD's Valuation Ratios OXFD's Financial Strength Ratios OXFD's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2020, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:03+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.